A new study has raised serious concerns about Ozempic, the weight-loss drug taking the world by storm. While it has reportedly helped many people manage their weight and regulate blood sugar, recent research has uncovered an alarming and unexpected side effect: vision loss.

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while taking widely used diabetes and weight loss drugs. The medications in question—semaglutide and tirzepatide—are the active ingredients in Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces the risk of major cardiovascular events, such as heart a

New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious concerns.